July 25, 2016


Side Effects


ZADAXIN (thymalfasin) is well tolerated. During clinical experience involving over 2000 individuals with various diseases distributed over all age groups, no clinically significant adverse reactions attributable to thymosin alpha 1 administration were reported (see table below).

  Disease Adverse Event Rate
Viral Infection Chronic hepatitis B Chronic hepatitis C Human immunodeficiency < 1% drug related adverse events for all indications
Cancer Non-small cell lung cancer Melanoma  
Vaccine adjuvant Hepatitis B vaccine Influenza vaccine
Immune disorders Autoimmune liver disease Primary immune deficiency

Adverse experiences have been infrequent and mild, consisting primarily of local discomfort at the injection site, and rare instances of erythema, transient muscle atrophy, polyarthralgia combined with hand edema, and rash.

Read the Zadaxin (thymalfasin) Side Effects Center for a complete guide to possible side effects


Drug Interactions and Incompatibilities

Interactions between ZADAXIN (thymalfasin) and other drugs have not been fully evaluated. Caution should be exercised when administering ZADAXIN (thymalfasin) therapy in combination with other immunomodulating drugs ZADAXIN (thymalfasin) should not be mixed with any other drug

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 3/3/2009

Side Effects

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.